Why Screening Matters
Hydroxychloroquine retinopathy develops when the medication accumulates in the retina, causing irreversible damage. While the condition is rare, it can progress silently until noticeable vision loss occurs. Fortunately, early detection through regular screening enables timely intervention, preventing further damage.
Optometrist Jigna Teli, who delivers the service, explains:
“It is great to finally have a community screening service available. Although retinopathy is rare, we have known for years that the Royal College [of Ophthalmologists] has recommended screening, but there wasn’t a service available for patients to access.”
Now, patients in South East London can benefit from a local screening service that adheres to the Royal College of Ophthalmologists’ guidelines, offering convenient access to this critical eye health service.
Enhanced Peace of Mind
For patients who do not yet qualify for the screening service, Linklater & Warren offers an alternative. The Linklater Warren Eye Examination includes the same advanced imaging and diagnostic tools used to detect hydroxychloroquine retinopathy.
“Many people taking hydroxychloroquine choose to visit us annually for this comprehensive examination,” says Jigna. “It’s great to provide reassurance that their eyes remain healthy, allowing them to take their medications with confidence.”
This enhanced eye examination costs £110, or £65 for students or those eligible for NHS Sight Tests. Visionplan members can access eye examinations as often as needed for a small monthly fee, making it easier to maintain regular monitoring while saving on essential services and eyewear.
Book Your Appointment
If you’re taking hydroxychloroquine and meet the screening criteria speak to your GP or prescribing doctor to request referral into the service. For those simply wanting the reassurance of a thorough eye health check; contact one of the Linklater & Warren Opticians branches today.
Browse Journals
Visionplan
